| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |